recombinant measles virus vaccine therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant measles virus vaccine therapy, covering 2017-10-02 to 2017-10-02. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 1]